داروسازی ابوریحان
دابور | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 65,540 2.99
Close Price: 65,560
Financial Ratios
AGM
Interim
2026/06/29 Fiscal Year 2026/03/2012 Month | 2025/06/08 Fiscal Year 2025/03/2012 Month | 2024/05/14 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Net Profit to Sales | 32.52 | 13.43 | 13.11 | |
Gross Profit to Sales | 40.75 | 18.27 | 18.19 | |
Operating Margin | 46.62 | 32.65 | 34.07 | |
Gross Profit to Sales | 53.09 | 39.41 | 40.3 | |
Net Profit to Gross Profit | 61.25 | 34.09 | 32.53 | |
Return on Assets (ROA) | 32.39 | 9.7 | 8.69 | |
Return on Capital (%) | 611.75 | 122.47 | 102.96 | |
Return on Equity (ROE) | 76.02 | 47.22 | 42.98 | |
Working Capital Return | 74.63 | 48.58 | 46.53 | |
Fixed Asset Return | 2,566.56 | 510.67 | 431.54 | |
Loan Benefit Assessment | 2.35 | 4.87 | 4.94 | |
Current Ratio | 1.79 | 1.26 | 1.24 | |
Quick Ratio | 1.4 | 1.03 | 1.01 | |
Liquidity Ratio | 0.03 | 0.03 | 0.02 | |
Net Working Capital | 14,755,667 | 4,537,996 | 3,982,943 | |
Current Assets Ratio | 0.99 | 0.98 | 0.97 | |
Inventory Turnover | 128.14 | 141.34 | 142.84 | |
Receivables Collection Period | 241.59 | 364.89 | 402.69 | |
Inventory to Working Capital | 0.49 | 0.87 | 0.94 | |
Working Capital Turnover | 2.29 | 3.62 | 3.55 | |
Fixed Asset Turnover | 78.93 | 38.01 | 32.91 | |
Total Asset Turnover | 1 | 0.72 | 0.66 | |
Debt Ratio | 0.57 | 0.79 | 0.8 | |
Debt to Equity | 1.35 | 3.87 | 3.94 | |
Long-Term Debt to Equity | 0.05 | 0.09 | 0.06 | |
Current Debt to Equity | 1.3 | 3.78 | 3.88 | |
Equity Ratio | 42.61 | 20.55 | 20.23 | |
Debt Coverage Ratio | 0.57 | 1.04 | 1.58 |